The answer often comes down to peptide vs GLP-1 mechanism
Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al
Relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events
Changes to diet and exercise are often combined with this medication
#ObesityCare #GLP1 #GLP1Medications #PublicHealth #WeightStigma #HealthEquity #ObesityTreatment #PatientSupport #HealthcareAccess #ObesityResearch #PersonCentredCare #HealthInequalities Registered Dietitian | Obesity Care & Health Strategy | Behavioural Science in Digital Health | Behavioural Intervention Design | Clinical Innovation New consensus statement, out this week in The Lancet Diabetes & Endocrinology, from European Association for the Study of Obesity (EASO), The European Federation of the Associations of Dietitians (EFAD) and ECPObesity: "Nutritional, functional, and psychological considerations for incretin-based therapies in adults." Link in comments